Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Non Operating Income (2016 - 2025)

CorMedix has reported Non Operating Income over the past 12 years, most recently at -$2.7 million for Q4 2025.

  • Quarterly results put Non Operating Income at -$2.7 million for Q4 2025, down 9.55% from a year ago — trailing twelve months through Dec 2025 was -$124999.0 (down 319.29% YoY), and the annual figure for FY2025 was -$125000.0, down 319.3%.
  • Non Operating Income reached -$2.7 million in Q4 2025 per CRMD's latest filing, down from $1.2 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $1.2 million in Q3 2025 and bottomed at -$2.7 million in Q4 2025.
  • Median Non Operating Income over the past 5 years was $315115.0 (2022), compared with a mean of $143219.2.
  • The largest annual shift saw Non Operating Income crashed 379.88% in 2021 before it skyrocketed 24647.35% in 2023.
  • Over 5 years, Non Operating Income stood at -$11066.0 in 2021, then soared by 1729.11% to $180277.0 in 2022, then skyrocketed by 407.39% to $914715.0 in 2023, then crashed by 367.43% to -$2.4 million in 2024, then dropped by 9.55% to -$2.7 million in 2025.
  • Business Quant data shows Non Operating Income for CRMD at -$2.7 million in Q4 2025, $1.2 million in Q3 2025, and $805983.0 in Q2 2025.